JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2017, Vol. 31 ›› Issue (4): 94-97.doi: 10.6040/j.issn.1673-3770.0.2016.227

Previous Articles     Next Articles

Combination of intravitreal ranibizumab with photodynamic therapy in the treatment of wet age-related macular degeneration.

WANG Cui, YAN Xin, ZHAO Bojun   

  1. Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Received:2016-05-19 Online:2017-08-16 Published:2017-08-16

Abstract: Objective To investigate the potential long-term benefit of combination of intravitreal ranibizumab with photodynamic therapy for the treatment for wet age-related macular degeneration(wAMD). Methods A retrospective review was conducted on 11 eyes of 11 patients that received intravitreal ranibizumab(IVR)0.5 mg combined with standard photodynamic therapy(PDT)within 7 days, and thereafter retreatment as required with intravitreal ranibizumab monotherapy for at least 18 months. Collected data included: best-corrected visual acuity(BCVA), central retinal thickness(CRT), intraocular pressure(IOP)and number of retreatment. Results The mean BCVA was apparently improved from baseline at the 2nd, 3rd and 6th month of follow-up compared to baseline(P<0.05, showing improvement of 7.31±15.00 letters from baseline at eighteen months of follow-up. )Meanwhile, CRT decreased significantly compared with pre-treatment(P<0.05). During the treatment, IOP kept steady with no statistical difference between pre- and post-treatment.The study eyes received an average of 1.55 times(range: 0 to 8)of intravitreal anti-VEGF reagent injection during the total 18 months period after initial combination therapy. Conclusion Combination therapy could reduce times of intravitreal anit-VEGF reagent injection and maintaine long-lasting effect on wAMD.

Key words: Wet age-related macular degeneration, Vascular endothelial growth factor, Photodynamic therapy, Combination therapy

CLC Number: 

  • R774
[1] Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents[J]. Ophthalmology, 2001, 108(4):697-704.
[2] Wong CW, Yanagi Y, Lee WK, et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians[J]. Prog Retin Eye Res, 2016, 53:107-139.
[3] 葛坚,何明光,赵家良,等. 我国九省眼病调查中广东省阳西县50岁及以上人群盲和中、重度视力损伤患病率及致病原因调查[J]. 中华眼科杂志,2014,50(3):167-172. GE Jian, HE Mingguang, ZHAO Jialiang, et al. Prevalence of blindness and moderate and severe visual impairment among adults aged 50 years or above in Yangxi county of Guangdong province: the china nine-province survey[J]. Chin J Ophthalmol, 2014, 50(3):167-172.
[4] 阴正勤,赵家良,李平华,等. 我国九省眼病调查中重庆市永川区50岁及以上人群盲和中、重度视力损伤患病率及致病原因调查[J]. 中华眼科杂志,2013,49(9):777-782. YIN Zhengqin, ZHAO Jialiang, LI Pinghua, et al. Prevalence and causes of blindness and moderate and severe visual impairment among adults aged 50 years or above in Yongchuan district of Chongqing city: the china nine-province survey[J]. Chin J Ophthalmol, 2013, 49(9):777-782.
[5] 吕建华,赵家良,Leon B.Ellwein,等. 我国九省眼病调查中河北省隆尧县50岁及以上人群盲和中、重度视力损伤患病率及致病原因调查[J]. 中华眼科杂志,2013,49(9):783-788. LV Jianhua, ZHAO Jialiang, Ellwein LB, et al. Prevalence and causes of blindness and moderate and severe visual impairment among adults aged 50 years or above in Longyao county of Hebei province: the china nine-province survey[J]. Chin J Ophthalmol, 2013, 49(9):783-788.
[6] Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis[J]. Lancet Glob Health, 2014, 2(2):106-116.
[7] Ferris FR, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy[J]. Arch Ophthalmol, 1984, 102(11):1640-1642.
[8] Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2[J]. Arch Ophthalmol, 2001, 119(2):198-207.
[9] Krebs I, Vecsei MV, Bodenstorfer J, et al. Comparison of ranibizumab monotherapy versus combination of ranibizumab with photodynamic therapy with neovascular age-related macular degeneration[J]. Acta Ophthalmol, 2013, 91(3):e178-e183.
[10] Larsen M, Schmidt-Erfurth U, Lanzetta P, et al. Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results[J]. Ophthalmology, 2012, 119(5):992-1000.
[11] Holladay JT. Visual acuity measurements[J]. J Cataract Refract Surg, 2004, 30(2):287-290.
[12] Tsuchihashi T, Mori K, Ueyama K, et al. Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration[J]. Clin Ophthalmol, 2013, 7:615-620.
[13] Stewart MW. individualized treatment of neovascular age-related macular degeneration: what are patients gaining or losing[J]. J Clin Med, 2015, 4(5):1079-1101.
[14] Si JK, Tang K, Bi HS, et al. Combination of ranibizumab with photodynamic therapy vs ranibizumab monotherapy in the treatment of age-related macular degeneration: a systematic review and meta-analysis of randomized controlled trials[J]. Int J Ophthalmol, 2014, 7(3):541-549.
[15] Chew EY, Clemons TE, Bressler SB, et al. Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye(HOME)study[J]. Ophthalmology, 2014, 121(2):535-544.
[16] Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C, et al. Influence of photodynamic therapy on expression of vascular endothelial growth factor(VEGF), VEGF receptor 3, and pigment epithelium-derived factor[J]. Invest Ophthalmol Vis Sci, 2003, 44(10):4473-4480.
[17] Simader C, Ritter M, Bolz M, et al. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration[J]. Ophthalmology, 2014, 121(6):1237-1245.
[18] Zhang S, An N, Ha W, et al. Factors correlated with the resolution of macular oedema after one dose injection of intravitreal triamcinolone acetonide treatment in branch retinal vein occlusion[J]. J Int Med Res, 2016, 44(3):685-697.
[1] LI Hao, LI Yanzhong, WANG Yan. Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression in the soft palate of [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 43-47.
[2] . Effects of PGMS on the expression of vascular endothelial growth factor in the rat of diabetic retinopathy. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(2): 90-95.
[3] ZHAO Lu, XIE Guoli, WANG Yanling. Changes of ocular hemodynamics after intravitreal ranibizumab injection in patients with wet age-related macular degeneration. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(4): 101-104.
[4] LI Yingying, ZHOU Han, ZHANG Weiqiang, DONG Weida. Effects of silencing hypoxia inducible factor-1α on the expression of cytokines in cultured human nasal epithelial cells [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 38-42.
[5] LI Junying. Effects of rosuvastatin combined with fenofibrate therapy on vascular endothelial function retinopathy diabetic retinopathy patients [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 72-75.
[6] DU Xiangge, ZHANG Yingchun, YAN Xin, WANG Cui, ZHAO Bojun. In vitro study of the effect of Casein Kinase2 siRNA on anginogesis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(3): 76-80.
[7] ZHANG Ying-chun, DU Xiang-ge, YAN Xin, WANG Cui, ZHAO Bo-jun. Effect of nicotine on human RPE cells and HUVECs [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(2): 74-80.
[8] MIAO Bei-ping1, ZHANG Rui-shi2, GUO Zhi-hong3, SUN Huan-ji1, MENG Qing-guo1, WANG Xiao-bin1. Correlation analysis of VEGF expression and the content of dendritic cells in nasopharyngeal carcinoma and its clinical significance [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(4): 62-65.
[9] XIE Li, WEI wei. Treatment progress of diabetic macular edema [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2): 81-85.
[10] LIU Shou-li, HAN Feng-qin. Clinical characteristics and treatment of 11 patients with Behcet’s disease [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2): 64-65.
[11] HU Ke-jin1, TANG Yao-yun2, ZHAO Su-ping2. 1. Biological behavior evaluation of nasopharyngeal carcinoma cells that survived from multiple 5-ALA mediated photodynamic therapies [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(3): 33-36.
[12] LI Li-hua, REN Ji-hao, YIN Tuan-fang, LIU Wei. Role of expressions of STAT3,VEGF and micro-vessel density in recurrence and invasiveness of juvenile [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(6): 11-.
[13] HAN Xuguang1,2, WU Xinyi1, QU Fei3, SUN Yan2, WANG Xu2, XU Xianghui2
.

Corneal neovascularization induced by suture and alkali burn in rabbits: an experimental study

[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2009, 23(2): 79-82 .
[14] GAO Ying,PAN Xin-liang,WANG Yan,LIU Ping-yun . Expression and significance of VEGF in nasal polyps [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(2): 150-152 .
[15] MA Xiao-hua,BI Hong-sheng,LI Jing-hai,XIE Xiao-feng,WU Jian-feng,JI Peng . Effect of 17β-estradiol on VEGF and HIF-1α mRNA expressions in bovine retinal vascular endothelial cells [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(1): 6-09 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!